Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

Clinical Infectious Diseases

Volumn 51, Issue 12, 2010, Pages

  Bate, Jessica ^a,b   Yung, Chee Fu ^c   Hoschler, Katja ^c   Sheasby, Liz ^c   Morden, James ^d   Taj, Mary ^b,d   Heath, Paul T ^a   Miller, Elizabeth ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; SWINE INFLUENZA VACCINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD SAMPLING; BRAIN TUMOR; CANCER PATIENT; CANCER THERAPY; CHILD; FEMALE; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGY; INFECTION SENSITIVITY; INFLUENZA A (H1N1); LYMPHOCYTOPENIA; LYMPHOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; SOLID TUMOR; UNITED KINGDOM; UNIVARIATE ANALYSIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ALPHA-TOCOPHEROL; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; GREAT BRITAIN; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; NEOPLASMS; POLYSORBATES; SQUALENE; VACCINATION;

EID: 78649979418     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/657403     Document Type: Article

References (25)

1. Chisholm JC, Devine T, Charlett A, et al. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001; 84:496-500.
2. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer: 20 cases. Cancer 1977; 39(1):350-353. (Pubitemid 8027746)
3. Kempe A, Hall CB, MacDonald NE, et al. Influenza in children with cancer. J Pediatr 1989; 115:33-39.
4. Tasian SK, Park JR, Martin ET, Englund JA. Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer 2008; 50(5):983-987.
5. Kersun LS, Coffin SE, Leckerman KH, Ingram M, Reilly AF. Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer. Pediatr Blood Cancer 2010; 54(1):79-82.
6. Royal College of Paediatrics and Child Health (RCPCH). Immunisation of the immunocompromised child. Best practice statement. RCPCH, 2002.
7. Chisholm J, Howe K, Taj M, Zambon M. Influenza immunisation in children with solid tumours. Eur J Cancer 2005; 41(15):2280-2287.
8. Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunisation in children receiving maintenance chemotherapy for acute lymphoblastic leukaemia. Pediatr Blood Cancer 2004; 42(1): 36-40. (Pubitemid 38173455)
9. Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer 2010; 54(5):716-720.
10. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361(7):680-689.
11. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58(17):467-470.
12. WHO. Influenza A (H1N1) - update 14. http://www.who.int/csr/don/2009-05- 04a/en/index.html. Accessed 21 October 2009.
13. Chironna M, Tafuri S, Santoro N, Prato R, Quarto M, Germinario CA. A nosocomial outbreak of 2009 pandemic influenza A(H1N1) in a paediatric oncology ward in Italy, October-November 2009. Euro Surveill 2010; 15(1):19454.
14. Launes C, Rives S, Català A, et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol 2010; 149(6):874-878.
15. Pandemrix. Summary of Product Characteristics, approved by the European Commission on 22 December 2009. GlaxoSmithKlein, Germany. 2009. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR---Product-Information/ human/000832/WC500038121.pdf. Accessed 20 April 2009.
16. Ellis JS, Zambon MC. Molecular analysis of an outbreak of influenza in the United Kingdom. Eur J Epidemiol 1997; 13(4):369-372.
17. Clark TW, Pareek M, Hoschler K, et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361(25):2424-2435.
18. Williams S, MacDonald P, Hoyer JD, Barr RD, Athale UH. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatr Blood Cancer 2005; 44(1):55-62. (Pubitemid 39602568)
19. Medicines and Healthcare Products Regulatory Agency (MHRA). Final public summary. UK suspected adverse reaction analysis swine flu (H1N1) vaccines - Celvapan and Pandemrix. 26 March 2010. MHRA, Department of Health, 2010.
20. Mitchell C, Richards S, Harrison CJ, Eden T. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia 2010; 24(2):406-418.
21. Gross PA, Lee H, Wolff JA, et al. Influenza immunization in children with cancer. J Pediatr 1978; 92:30-35.
22. Lange B, Shapiro SA, Waldman MTG, et al. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J Infect Dis 1979; 140(3):402-406. (Pubitemid 10189483)
23. Vesikari T, Pellegrini M, Karvonen A, et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J 2009; 28(7):563-571.
24. Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010; 340:c2649.
25. Seubert A, Monaci E, Pizza M, O'Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 2008; 180(8):5402-5412.